Mobile element insertions in rare diseases: a comparative benchmark and reanalysis of 60,000 exome samples.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
19 Oct 2023
Historique:
received: 01 11 2022
accepted: 04 10 2023
revised: 29 08 2023
pubmed: 19 10 2023
medline: 19 10 2023
entrez: 18 10 2023
Statut: aheadofprint

Résumé

Mobile element insertions (MEIs) are a known cause of genetic disease but have been underexplored due to technical limitations of genetic testing methods. Various bioinformatic tools have been developed to identify MEIs in Next Generation Sequencing data. However, most tools have been developed specifically for genome sequencing (GS) data rather than exome sequencing (ES) data, which remains more widely used for routine diagnostic testing. In this study, we benchmarked six MEI detection tools (ERVcaller, MELT, Mobster, SCRAMble, TEMP2 and xTea) on ES data and on GS data from publicly available genomic samples (HG002, NA12878). For all the tools we evaluated sensitivity and precision of different filtering strategies. Results show that there were substantial differences in tool performance between ES and GS data. MELT performed best with ES data and its combination with SCRAMble increased substantially the detection rate of MEIs. By applying both tools to 10,890 ES samples from Solve-RD and 52,624 samples from Radboudumc we were able to diagnose 10 patients who had remained undiagnosed by conventional ES analysis until now. Our study shows that MELT and SCRAMble can be used reliably to identify clinically relevant MEIs in ES data. This may lead to an additional diagnosis for 1 in 3000 to 4000 patients in routine clinical ES.

Identifiants

pubmed: 37853102
doi: 10.1038/s41431-023-01478-7
pii: 10.1038/s41431-023-01478-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s).

Références

Mc CB. The origin and behavior of mutable loci in maize. Proc Natl Acad Sci USA. 1950;36:344–55.
doi: 10.1073/pnas.36.6.344
Hancks DC, Kazazian HH Jr. Roles for retrotransposon insertions in human disease. Mob Dna 2016;7:9.
doi: 10.1186/s13100-016-0065-9 pubmed: 27158268 pmcid: 4859970
Mills RE, Bennett EA, Iskow RC, Devine SE. Which transposable elements are active in the human genome? Trends Genet. 2007;23:183–91.
doi: 10.1016/j.tig.2007.02.006 pubmed: 17331616
Stewart C, Kural D, Stromberg MP, Walker JA, Konkel MK, Stutz AM, et al. A comprehensive map of mobile element insertion polymorphisms in humans. PLoS Genet. 2011;7:e1002236.
doi: 10.1371/journal.pgen.1002236 pubmed: 21876680 pmcid: 3158055
Tang W, Mun S, Joshi A, Han K, Liang P. Mobile elements contribute to the uniqueness of human genome with 15,000 human-specific insertions and 14 Mbp sequence increase. DNA Res. 2018;25:521–33.
doi: 10.1093/dnares/dsy022 pubmed: 30052927 pmcid: 6191304
Cordaux R, Batzer MA. The impact of retrotransposons on human genome evolution. Nat Rev Genet. 2009;10:691–703.
doi: 10.1038/nrg2640 pubmed: 19763152 pmcid: 2884099
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860–921.
doi: 10.1038/35057062 pubmed: 11237011
Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, et al. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci USA. 2003;100:5280–5.
doi: 10.1073/pnas.0831042100 pubmed: 12682288 pmcid: 154336
Beck CR, Collier P, Macfarlane C, Malig M, Kidd JM, Eichler EE, et al. LINE-1 retrotransposition activity in human genomes. Cell 2010;141:1159–70.
doi: 10.1016/j.cell.2010.05.021 pubmed: 20602998 pmcid: 3013285
Xing J, Zhang Y, Han K, Salem AH, Sen SK, Huff CD, et al. Mobile elements create structural variation: analysis of a complete human genome. Genome Res. 2009;19:1516–26.
doi: 10.1101/gr.091827.109 pubmed: 19439515 pmcid: 2752133
Niu Y, Teng X, Zhou H, Shi Y, Li Y, Tang Y, et al. Characterizing mobile element insertions in 5675 genomes. Nucleic Acids Res. 2022;50:2493–508.
doi: 10.1093/nar/gkac128 pubmed: 35212372 pmcid: 8934628
Ewing AD, Kazazian HH Jr. High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res. 2010;20:1262–70.
doi: 10.1101/gr.106419.110 pubmed: 20488934 pmcid: 2928504
Torene RI, Galens K, Liu S, Arvai K, Borroto C, Scuffins J, et al. Mobile element insertion detection in 89,874 clinical exomes. Genet Med. 2020;22:974–8.
doi: 10.1038/s41436-020-0749-x pubmed: 31965078 pmcid: 7200591
Gardner EJ, Prigmore E, Gallone G, Danecek P, Samocha KE, Handsaker J, et al. Contribution of retrotransposition to developmental disorders. Nat Commun. 2019;10:4630.
doi: 10.1038/s41467-019-12520-y pubmed: 31604926 pmcid: 6789007
Demidov G, Park J, Armeanu-Ebinger S, Roggia C, Faust U, Cordts I, et al. Detection of mobile elements insertions for routine clinical diagnostics in targeted sequencing data. Mol Genet Genom Med. 2021;9:e1807.
doi: 10.1002/mgg3.1807
Gardner EJ, Lam VK, Harris DN, Chuang NT, Scott EC, Pittard WS, et al. The Mobile Element Locator Tool (MELT): population-scale mobile element discovery and biology. Genome Res. 2017;27:1916–29.
doi: 10.1101/gr.218032.116 pubmed: 28855259 pmcid: 5668948
Thung DT, de Ligt J, Vissers LE, Steehouwer M, Kroon M, de Vries P, et al. Mobster: accurate detection of mobile element insertions in next generation sequencing data. Genome Biol. 2014;15:488.
doi: 10.1186/s13059-014-0488-x pubmed: 25348035 pmcid: 4228151
Rishishwar L, Marino-Ramirez L, Jordan IK. Benchmarking computational tools for polymorphic transposable element detection. Brief Bioinform. 2017;18:908–18.
pubmed: 27524380
Vendrell-Mir P, Barteri F, Merenciano M, Gonzalez J, Casacuberta JM, Castanera R. A benchmark of transposon insertion detection tools using real data. Mob DNA. 2019;10:53.
doi: 10.1186/s13100-019-0197-9 pubmed: 31892957 pmcid: 6937713
Zurek B, Ellwanger K, Vissers L, Schule R, Synofzik M, Topf A, et al. Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases. Eur J Hum Genet. 2021;29:1325–31.
doi: 10.1038/s41431-021-00859-0 pubmed: 34075208 pmcid: 8440542
Chen X, Li D. ERVcaller: identifying polymorphic endogenous retrovirus and other transposable element insertions using whole-genome sequencing data. Bioinformatics 2019;35:3913–22.
doi: 10.1093/bioinformatics/btz205 pubmed: 30895294
Yu T, Huang X, Dou S, Tang X, Luo S, Theurkauf WE, et al. A benchmark and an algorithm for detecting germline transposon insertions and measuring de novo transposon insertion frequencies. Nucleic Acids Res. 2021;49:e44.
doi: 10.1093/nar/gkab010 pubmed: 33511407 pmcid: 8096211
Chu C, Borges-Monroy R, Viswanadham VV, Lee S, Li H, Lee EA, et al. Comprehensive identification of transposable element insertions using multiple sequencing technologies. Nat Commun. 2021;12:3836.
doi: 10.1038/s41467-021-24041-8 pubmed: 34158502 pmcid: 8219666
McDonald TL, Zhou W, Castro CP, Mumm C, Switzenberg JA, Mills RE, et al. Cas9 targeted enrichment of mobile elements using nanopore sequencing. Nat Commun. 2021;12:3586.
doi: 10.1038/s41467-021-23918-y pubmed: 34117247 pmcid: 8196195
Kucuk E, van der Sanden B, O’Gorman L, Kwint M, Derks R, Wenger AM, et al. Comprehensive de novo mutation discovery with HiFi long-read sequencing. Genome Med. 2023;15:34.
doi: 10.1186/s13073-023-01183-6 pubmed: 37158973 pmcid: 10169305
Liao WW, Asri M, Ebler J, Doerr D, Haukness M, Hickey G, et al. A draft human pangenome reference. Nature 2023;617:312–24.
doi: 10.1038/s41586-023-05896-x pubmed: 37165242 pmcid: 10172123
Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–6.
doi: 10.1038/nbt.1754 pubmed: 21221095 pmcid: 3346182
Zook JM, Hansen NF, Olson ND, Chapman L, Mullikin JC, Xiao C, et al. A robust benchmark for detection of germline large deletions and insertions. Nat Biotechnol. 2020;38:1347–55.
doi: 10.1038/s41587-020-0538-8 pubmed: 32541955 pmcid: 8454654
Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature 2015;526:68–74.
doi: 10.1038/nature15393
Laurie S, Piscia D, Matalonga L, Corvo A, Fernandez-Callejo M, Garcia-Linares C, et al. The RD-connect genome-phenome analysis platform: accelerating diagnosis, research, and gene discovery for rare diseases. Hum Mutat. 2022;43:717–33.
pubmed: 35178824 pmcid: 9324157
Lelieveld SH, Reijnders MR, Pfundt R, Yntema HG, Kamsteeg EJ, de Vries P, et al. Meta-analysis of 2104 trios provides support for 10 new genes for intellectual disability. Nat Neurosci. 2016;19:1194–6.
doi: 10.1038/nn.4352 pubmed: 27479843
Wang J, Song L, Grover D, Azrak S, Batzer MA, Liang P. dbRIP: a highly integrated database of retrotransposon insertion polymorphisms in humans. Hum Mutat. 2006;27:323–9.
doi: 10.1002/humu.20307 pubmed: 16511833 pmcid: 1855216
Storer J, Hubley R, Rosen J, Wheeler TJ, Smit AF. The Dfam community resource of transposable element families, sequence models, and genome annotations. Mob DNA. 2021;12:2.
doi: 10.1186/s13100-020-00230-y pubmed: 33436076 pmcid: 7805219
Magrinelli F, Rocca C, Simone R, Zenezini Chiozzi R, Jaunmuktane Z, Mencacci NE, et al. Detection and characterization of a De Novo Alu retrotransposition event causing NKX2-1-related disorder. Mov Disord. 2023;38:347–53.
doi: 10.1002/mds.29280 pubmed: 36420574
Nelson MG, Linheiro RS, Bergman CM. McClintock: An Integrated Pipeline for Detecting Transposable Element Insertions in Whole-Genome Shotgun Sequencing Data. G3 (Bethesda). 2017;7:2763–78.
doi: 10.1534/g3.117.043893 pubmed: 28637810
van den Akker J, Hon L, Ondov A, Mahkovec Z, O’Connor R, Chan RC, et al. Intronic breakpoint signatures enhance detection and characterization of clinically relevant germline structural variants. J Mol Diagn. 2021;23:612–29.
doi: 10.1016/j.jmoldx.2021.01.015 pubmed: 33621668
Qian Y, Mancini-DiNardo D, Judkins T, Cox HC, Brown K, Elias M, et al. Identification of pathogenic retrotransposon insertions in cancer predisposition genes. Cancer Genet. 2017;216-217:159–69.
doi: 10.1016/j.cancergen.2017.08.002 pubmed: 29025590
Chen X, Schulz-Trieglaff O, Shaw R, Barnes B, Schlesinger F, Kallberg M, et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinformatics 2016;32:1220–2.
doi: 10.1093/bioinformatics/btv710 pubmed: 26647377
Gardner EJ, Sifrim A, Lindsay SJ, Prigmore E, Rajan D, Danecek P, et al. Detecting cryptic clinically relevant structural variation in exome-sequencing data increases diagnostic yield for developmental disorders. Am J Hum Genet. 2021;108:2186–94.
doi: 10.1016/j.ajhg.2021.09.010 pubmed: 34626536 pmcid: 8595893

Auteurs

Robin Wijngaard (R)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.

German Demidov (G)

Universitätsklinikum Tübingen - Institut für Medizinische Genetik und angewandte Genomik, Tübingen, Germany.

Luke O'Gorman (L)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Jordi Corominas-Galbany (J)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Burcu Yaldiz (B)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Wouter Steyaert (W)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Elke de Boer (E)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.

Lisenka E L M Vissers (LELM)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.

Erik-Jan Kamsteeg (EJ)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.

Rolph Pfundt (R)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Hilde Swinkels (H)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Amber den Ouden (A)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Iris B A W Te Paske (IBAW)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Richarda M de Voer (RM)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Laurence Faivre (L)

Centre de Référence Maladies Rares "Anomalies du développement et syndromes malformatifs", Centre de Génétique, FHU-TRANSLAD et Institut GIMI, CHU Dijon Bourgogne, Dijon, France.

Anne-Sophie Denommé-Pichon (AS)

UMR1231-Inserm, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.
Laboratoire de Génétique chromosomique et moléculaire, UF6254 Innovation en diagnostic génomique des maladies rares, Centre Hospitalier Universitaire de Dijon, Dijon, France.

Yannis Duffourd (Y)

UMR1231-Inserm, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.
Laboratoire de Génétique chromosomique et moléculaire, UF6254 Innovation en diagnostic génomique des maladies rares, Centre Hospitalier Universitaire de Dijon, Dijon, France.

Antonio Vitobello (A)

UMR1231-Inserm, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.
Laboratoire de Génétique chromosomique et moléculaire, UF6254 Innovation en diagnostic génomique des maladies rares, Centre Hospitalier Universitaire de Dijon, Dijon, France.

Martin Chevarin (M)

UMR1231-Inserm, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.
Laboratoire de Génétique chromosomique et moléculaire, UF6254 Innovation en diagnostic génomique des maladies rares, Centre Hospitalier Universitaire de Dijon, Dijon, France.

Volker Straub (V)

John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Ana Töpf (A)

John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Anneke J van der Kooi (AJ)

Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Francesca Magrinelli (F)

Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.

Clarissa Rocca (C)

Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Clinical Pharmacology, William Harvey Research Institute, School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Michael G Hanna (MG)

Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.

Jana Vandrovcova (J)

Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.

Stephan Ossowski (S)

Universitätsklinikum Tübingen - Institut für Medizinische Genetik und angewandte Genomik, Tübingen, Germany.

Steven Laurie (S)

Centro Nacional de Análisis Genómico (CNAG), Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.

Christian Gilissen (C)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. Christian.gilissen@radboudumc.nl.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. Christian.gilissen@radboudumc.nl.

Classifications MeSH